Neuropeptides in neurological disease (Q39480436)

12 September 2017

1 reference

title

Neuropeptides in neurological disease (English)

1 reference

12 September 2017

Beal MF

1

1 reference

PubMed ID

2947536

12 September 2017

Martin JB

series ordinal

2

1 reference

12 September 2017

1 November 1986

1 reference

12 September 2017

1 reference

12 September 2017

20

1 reference

12 September 2017

5

1 reference

12 September 2017

547-565

1 reference

Somatostatin is increased in the nucleus accumbens in Huntington's disease

12 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200502

CSF somatostatin-like immunoreactivity in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200502

Huntington's disease: New approaches to an old problem: The Robert Wartenberg Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200502

beta-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200502

Substance P in human cerebrospinal fluid: Reductions in peripheral neuropathy and autonomic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200502

CSF Somatostatin in Affective Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200502

21 January 2018

Identifiers

DOI

10.1002/ANA.410200502

1 reference

12 September 2017

1 reference

PubMed ID

2947536